Total Payments
$9,190
2024 Payments
$711.06
Companies
46
Transactions
685
Medicare Patients
23,688
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$9,185 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,185 | 684 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,612 | 95 | $0 (2024) |
| PFIZER INC. | $972.35 | 84 | $0 (2023) |
| ABBVIE INC. | $926.42 | 88 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $886.49 | 44 | $0 (2024) |
| Amgen Inc. | $495.18 | 39 | $0 (2024) |
| Allergan, Inc. | $470.49 | 70 | $0 (2020) |
| GlaxoSmithKline, LLC. | $463.02 | 37 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $462.65 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $413.87 | 41 | $0 (2024) |
| Novo Nordisk Inc | $382.19 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $711.06 | 31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($243.65) |
| 2023 | $1,138 | 76 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($306.19) |
| 2022 | $995.28 | 69 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($289.53) |
| 2021 | $1,384 | 92 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($266.24) |
| 2020 | $1,140 | 83 | PFIZER INC. ($218.66) |
| 2019 | $923.56 | 86 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($160.05) |
| 2018 | $914.09 | 69 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($149.17) |
| 2017 | $1,984 | 179 | AstraZeneca Pharmaceuticals LP ($318.59) |
All Payment Transactions
685 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neuromodulation | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.85 | General |
| 08/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BOOSTRIX | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, BOOSTRIX | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Gastroenterology | ||||||
| 04/16/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 04/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Gastroenterology | ||||||
| 02/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 5,654 | 10,881 | $576,734 | $282,513 |
| 2022 | 42 | 5,554 | 9,376 | $538,349 | $251,522 |
| 2021 | 45 | 6,072 | 11,085 | $586,548 | $276,631 |
| 2020 | 49 | 6,408 | 11,517 | $592,879 | $253,988 |
Total Patients
23,688
Total Services
42,859
Medicare Billing
$1.1M
Procedure Codes
185
All Medicare Procedures & Services
185 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 664 | 1,236 | $154,500 | $90,670 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 446 | 867 | $73,695 | $47,884 | 65.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 106 | 747 | $48,555 | $31,931 | 65.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,260 | $30,600 | $22,766 | 74.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 93 | 315 | $15,750 | $10,477 | 66.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 539 | 803 | $56,210 | $10,461 | 18.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 662 | 1,219 | $24,380 | $10,134 | 41.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 620 | 1,002 | $42,084 | $8,230 | 19.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 36 | 36 | $7,200 | $5,177 | 71.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 136 | 137 | $4,795 | $4,314 | 90.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 136 | 137 | $4,795 | $3,815 | 79.6% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 501 | 734 | $14,680 | $3,790 | 25.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 175 | 214 | $11,770 | $3,468 | 29.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 212 | 357 | $13,209 | $3,367 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $2,990 | $2,999 | 100.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 74 | 76 | $6,460 | $2,631 | 40.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 58 | 69 | $3,450 | $2,573 | 74.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 207 | 274 | $10,138 | $2,070 | 20.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 60 | 124 | $3,100 | $2,011 | 64.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 34 | 61 | $2,440 | $1,684 | 69.0% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 32 | 37 | $2,775 | $1,385 | 49.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 152 | $5,320 | $1,379 | 25.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 30 | 33 | $2,640 | $957.33 | 36.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 48 | $3,840 | $954.78 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,090 | $940.94 | 45.0% |
About Dr. Terry Lowe, MD
Dr. Terry Lowe, MD is a Family Medicine healthcare provider based in Hattiesburg, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508860123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terry Lowe, MD has received a total of $9,190 in payments from pharmaceutical and medical device companies, with $711.06 received in 2024. These payments were reported across 685 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,185).
As a Medicare-enrolled provider, Lowe has provided services to 23,688 Medicare beneficiaries, totaling 42,859 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 185 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hattiesburg, MS
- Active Since 06/10/2005
- Last Updated 11/16/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508860123
Products in Payments
- XIFAXAN (Drug) $1,664
- VRAYLAR (Drug) $572.71
- FARXIGA (Drug) $567.70
- JARDIANCE (Drug) $387.29
- TRINTELLIX (Drug) $332.06
- CHANTIX (Drug) $269.75
- UBRELVY (Drug) $236.92
- LYRICA (Drug) $231.16
- TRULICITY (Drug) $210.06
- QULIPTA (Drug) $177.09
- AIRSUPRA (Drug) $176.36
- Ozempic (Drug) $170.59
- Aimovig (Biological) $168.30
- EVENITY (Biological) $160.65
- TRELEGY ELLIPTA (Drug) $148.26
- ELIQUIS (Drug) $145.90
- LINZESS (Drug) $134.77
- AREXVY (Drug) $133.79
- VYVANSE (Drug) $122.33
- Victoza (Drug) $117.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hattiesburg
Omolara Otaigbe, Md, MD
Family Medicine — Payments: $28,883
Family Medicine $28,883
Dr. Deborah Copeland, M.d, M.D
Family Medicine — Payments: $16,017
Family Medicine $16,017
Mr. J Dumas, Md, MD
Family Medicine — Payments: $15,138
Family Medicine $15,138
Dr. Melanie Hall, M.d, M.D
Family Medicine — Payments: $12,717
Family Medicine $12,717
Dr. Stephen Lambert, Md, MD
Family Medicine — Payments: $9,907
Family Medicine $9,907
Dr. Rambod Rouhbakhsh, Md, MD
Family Medicine — Payments: $9,437
Family Medicine $9,437